Citation: | Chuan-Jun Shu, Xuan Huang, Hui-Hao Tang, Ding-Ding Mo, Jian-Wei Zhou, Cheng Deng. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2. Zoological Research, 2021, 42(2): 170-181. doi: 10.24272/j.issn.2095-8137.2020.301 |
[1] |
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. 2020. Remdesivir for the treatment of Covid-19-preliminary report. New England Journal of Medicine, 383(10): 992−994. doi: 10.1056/NEJMc2022236
|
[2] |
Boas LCPV, Campos ML, Berlanda RLA, De Carvalho Neves N, Franco OL. 2019. Antiviral peptides as promising therapeutic drugs. Cellular and Molecular Life Sciences, 76(18): 3525−3542. doi: 10.1007/s00018-019-03138-w
|
[3] |
Cao YN, Li L, Feng ZM, Wan SQ, Huang PD, Sun XH, et al. 2020a. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discovery, 6(1): 11. doi: 10.1038/s41421-020-0147-1
|
[4] |
Cao YN, Li L, Xu M, Feng ZM, Sun XH, Lu JL, et al. 2020b. The ChinaMAP analytics of deep whole genome sequences in 10, 588 individuals. Cell Research, 30(9): 717−731. doi: 10.1038/s41422-020-0322-9
|
[5] |
Chen C, Zhang Y, Huang JY, Yin P, Cheng ZS, Wu JY, et al. 2020. Favipiravir versus Arbidol for COVID-19: a randomized clinical trial. medRxiv. doi: 10.1101/2020.03.17.20037432.
|
[6] |
Fang L, Karakiulakis G, Roth M. 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet Respiratory Medicine, 8(4): e21. doi: 10.1016/S2213-2600(20)30116-8
|
[7] |
Gao Q, Bao LL, Mao HY, Wang L, Xu KW, Yang MN, et al. 2020. Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 369(6499): 77−81. doi: 10.1126/science.abc1932
|
[8] |
Gao YD, Huang JF. 2011. An extension strategy of discovery studio 2.0 for non-bonded interaction energy automatic calculation at the residue level. Zoological Research, 32(3): 262−266.
|
[9] |
Garg VK, Avashthi H, Tiwari A. 2016. MFPPI–Multi FASTA ProtParam interface. Bioinformation, 12(2): 74−77. doi: 10.6026/97320630012074
|
[10] |
Geleris J, Sun Y, Platt J, Zucker J, Baldwin MR, Hripcsak G, et al. 2020. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine, 382(25): 2411−2418. doi: 10.1056/NEJMoa2012410
|
[11] |
Gu HJ, Xie ZD, Li TL, Zhang SG, Lai CC, Zhu P, et al. 2016. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Scientific Reports, 6(1): 19840. doi: 10.1038/srep19840
|
[12] |
Hamzelou J. 2020. Does a cell protein explain covid-19 severity?. New Scientist, 246(3277): 9. doi: 10.1016/S0262-4079(20)30705-3
|
[13] |
Holshue ML, Debolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. 2020. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine, 382(10): 929−936. doi: 10.1056/NEJMoa2001191
|
[14] |
Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al. 2020a. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223): 497−506. doi: 10.1016/S0140-6736(20)30183-5
|
[15] |
Huang MX, Li M, Xiao F, Pang PF, Liang JB, Tang TT, et al. 2020b. Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19. National Science Review, 7(9): 1428−1436. doi: 10.1093/nsr/nwaa113
|
[16] |
Imai Y, Kuba K, Penninger JM. 2007. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cellular and Molecular Life Sciences, 64(15): 2006−2012. doi: 10.1007/s00018-007-6228-6
|
[17] |
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. 2016. Analysis of protein-coding genetic variation in 60,706 humans. Nature, 536(7616): 285−291. doi: 10.1038/nature19057
|
[18] |
Lewis PO, Kumar S, Tamura K, Nei M. 1995. MEGA: Molecular evolutionary genetics analysis, version 1.02. Systematic Biology, 44(4): 576−577.
|
[19] |
Li L, Zhang W, Hu Y, Tong XL, Zheng SG, Yang JT, et al. 2020a. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA, 324(5): 460−470. doi: 10.1001/jama.2020.10044
|
[20] |
Li QQ, Wu JJ, Nie JH, Zhang L, Hao H, Liu S, et al. 2020b. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell, 182(5): 1284−1294. doi: 10.1016/j.cell.2020.07.012
|
[21] |
Li XC, Zhang J, Zhuo JL. 2017. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacological Research, 125: 21−38. doi: 10.1016/j.phrs.2017.06.005
|
[22] |
Mirochnik Y, Aurora A, Schulze-Hoepfner FT, Deabes A, Shifrin V, Beckmann R, et al. 2009. Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clinical Cancer Research, 15(5): 1655−1663. doi: 10.1158/1078-0432.CCR-08-2113
|
[23] |
Ordog R. 2008. PyDeT, a PyMOL plug-in for visualizing geometric concepts around proteins. Bioinformation, 2(8): 346−347. doi: 10.6026/97320630002346
|
[24] |
Rohl CA, Strauss CEM, Misura KMS, Baker D. 2004. Protein structure prediction using Rosetta. Methods in Enzymology, 383: 66−93.
|
[25] |
Rozas J, Ferrer-Mata A, Sánchez-DelBarrio JC, Guirao-Rico S, Librado P, Ramos-Onsins SE, et al. 2017. DnaSP 6: DNA sequence polymorphism analysis of large data sets. Molecular Biology and Evolution, 34(12): 3299−3302. doi: 10.1093/molbev/msx248
|
[26] |
Shen CG, Wang ZQ, Zhao F, Yang Y, Li JX, Yuan J, et al. 2020. Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma. JAMA, 323(16): 1582−1589. doi: 10.1001/jama.2020.4783
|
[27] |
Shi JZ, Wen ZY, Zhong GX, Yang HL, Wang C, Huang BY, et al. 2020a. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science, 368(6494): 1016−1020. doi: 10.1126/science.abb7015
|
[28] |
Shi R, Shan C, Duan XM, Chen ZH, Liu PP, Song JW, et al. 2020b. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature, 584(7819): 120−124. doi: 10.1038/s41586-020-2381-y
|
[29] |
Shu CJ, Xiao K, Sun X. 2020. Structural basis for the high conductivity of microbial pili as potential nanowires. Journal of Nanoscience and Nanotechnology, 20(1): 64−80. doi: 10.1166/jnn.2020.16883
|
[30] |
Song WF, Gui M, Wang XQ, Xiang Y. 2018. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathogens, 14(8): e1007236. doi: 10.1371/journal.ppat.1007236
|
[31] |
Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. 2021. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. Nature, 590(7845): 290−299. doi: 10.1038/s41586-021-03205-y
|
[32] |
Tang XL, Wu CC, Li X, Song YH, Yao XM, Wu XK, et al. 2020. On the origin and continuing evolution of SARS-CoV-2. National Science Review, 7(6): 1012−1023. doi: 10.1093/nsr/nwaa036
|
[33] |
The 1000 Genomes Project Consortium. 2015. A global reference for human genetic variation. Nature, 526(7571): 68−74. doi: 10.1038/nature15393
|
[34] |
The UK10K Consortium. 2015. The UK10K project identifies rare variants in health and disease. Nature, 526(7571): 82−90. doi: 10.1038/nature14962
|
[35] |
Tippmann HF. 2004. Analysis for free: comparing programs for sequence analysis. Briefings in Bioinformatics, 5(1): 82−87. doi: 10.1093/bib/5.1.82
|
[36] |
Wang H, Zhang YT, Huang BY, Deng W, Quan YR, Wang WL, et al. 2020a. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell, 182(3): 713−721. doi: 10.1016/j.cell.2020.06.008
|
[37] |
Wang ML, Cao RY, Zhang LK, Yang XL, Liu J, Xu MY, et al. 2020b. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3): 269−271. doi: 10.1038/s41422-020-0282-0
|
[38] |
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. 2018. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1): W296−W303. doi: 10.1093/nar/gky427
|
[39] |
Wrapp D, Wang NS, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. 2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483): 1260−1263. doi: 10.1126/science.abb2507
|
[40] |
Zhao Y, Zhao ZX, Wang YJ, Zhou YQ, Ma Y, Zuo W. 2020. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. doi: 10.1101/2020.01.26.919985.
|
[41] |
Zheng YY, Ma YT, Zhang JY, Xie X. 2020. COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5): 259−260. doi: 10.1038/s41569-020-0360-5
|
![]() |
![]() |